The global mice model market was valued at US$1.01 bn in 2014. After exhibiting a CAGR of 6.40% within a forecast period from 2015 to 2023, this market is expected to reach US$1.7 bn by the end of it. This data has been compiled in a research report released by Transparency Market Research. The report, titled “Mice Model Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” provides a comparative analysis of the market’s various segments, and a conclusive description of the market’s future.
According to the report, the primary driver of the global mice model market is the growing level of research and development in the field of genetic technology. Mice models are being used increasingly in biomedical research in order to get better results in trials for human diseases and testing of new drugs.
The report links the global mice model market to major developments in the medical field, such as the introduction of efficacious treatment options for APL, which was previously considered to be a terminal disease. Mice models were used extensively in the development of new drug candidates for APL, thus driving the global mice model market.
The report also distinguishes mice models in comparison to other medical testing methods. Mice models can provide a precise correlation with the human symptoms of various diseases. Another top advantage of using mice models is the higher scope for exploring functions that are specific to human genetic coding through the molecular events inside a living organism.
The report provides a segmented view of the global mice model market, based on type, specialty, service, and geography.
In terms of type, the global mice model market was dominated by inbred mice models in 2014. This was attributed to their multiple benefits, such as higher data reproducibility and improved cost-effectiveness. Other segments include mice models that are surgically modified, transplanted, outbred, carcinogen-induced and spontaneous, knockout, hybrid or congenic, and transgenic.
In terms of specialty, the global mice model market is segmented into immunology, CNS, diabetes, oncology, metabolism and regulation, and cardiovascular. Of these, the global mice model market was led by the metabolic and regulation segment in 2014, while the segment of diabetes mice models is expected to rise at the highest growth rate within the report’s forecast period. The growing prevalence of diabetes will lead to better and faster research and development rates.
For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085
In terms of service, the global mice model market is being propelled by the increasing importance of providing customized mice models for various fields of applied research, along with the growing production levels and development efforts in the field of critical biomolecules.
Geographically, the report puts North America at the top position in the global mice model market for 2014. This regional market’s lead is attributed to the presence of a large number of top companies in it, which has given rise to major opportunities in biomedicine. The second place in the global mice model market for 2014 was held by Europe. At the same time, the report expects Asia Pacific to display the highest CAGR among all major regions for the given forecast period, owing to the rapid developments in research and infrastructure in developing economies such as China and India.
The key players in the global mice model market are TransGenic, Inc., The Jackson Laboratory, SAGE Labs, Lexicon Pharmaceuticals, Taconic Biosciences, Inc., ImmunoGenes AG, Harlan Laboratories, Inc., GenOway S.A., Deltagen, Inc., Crescendo Biologics Limited, and Charles River Laboratories.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.